Skip to main content
. 2019 Feb 6;10:82. doi: 10.3389/fphar.2019.00082

FIGURE 1.

FIGURE 1

(A–D) Longitudinal laboratory efficacy data at the first 12 visits of the 21 cases that passed the 3-month evaluation visit; (A) C-reactive protein, (B) erythrocyte sedimentation rate, (C) complement protein 3, and (D) complement protein 4. p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005.